Doxazosin Mesylate

CHEMBL1200561 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
547.6 g/mol
LogP
Phase
4

A mesylate salt form of doxazosin used to treat hypertension and benign prostatic hyperplasia. Like the parent compound, it relaxes smooth muscle in the blood vessels and urinary tract.

Berat Molekul

547,6000 g/mol

TPSA

175,00 Ų

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC.CS(=O)(=O)O

InChI

InChI=1S/C23H25N5O5.CH4O3S/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20;1-5(2,3)4/h3-6,11-12,20H,7-10,13H2,1-2H3,(H2,24,25,26);1H3,(H,2,3,4)

Molecular Formula

C24H29N5O8S

HBD / HBA

2 / 12

Ikatan yang Dapat Dirotasi

4

Atom Berat

38

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A mesylate salt form of doxazosin used to treat hypertension and benign prostatic hyperplasia. Like the parent compound, it relaxes smooth muscle in the blood vessels and urinary tract.

Yes, Doxazosin Mesylate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200561. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 62978. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.